Comment on: Recombinant human TSH in differentiated thyroid cancer: a nuclear medicine perspective

被引：2
|
作者：
Luster, Markus [1 ]
Schlumberger, Martin [2 ]
Pacini, Furio [3 ]
机构：
[1] Univ Ulm, Dept Nucl Med, D-89081 Ulm, Germany
[2] Inst Gustave Roussy, Dept Nucl Med & Endocrine Oncol, F-94805 Villejuif, France
[3] Univ Siena, Sect Endocrinol & Metab, Dept Internal Med, I-53100 Siena, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2009年 / 36卷 / 02期
关键词：
HORMONE WITHDRAWAL; RADIOIODINE THERAPY; MANAGEMENT; CARCINOMA; DOSIMETRY; ABLATION;
D O I：
10.1007/s00259-008-1013-9
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：329 / 330
页数：2
相关论文
共 50 条
  • [21] Radioiodine treatment of metastatic differentiated thyroid cancer in patients on L-thyroxine, using recombinant human TSH
    Lippi, F
    Capezzone, M
    Angelini, F
    Taddei, D
    Molinaro, E
    Pinchera, A
    Pacini, F
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2001, 144 (01) : 5 - 11
  • [22] On the effectiveness of recombinant human TSH as a stimulating agent for 131I treatment of metastatic differentiated thyroid cancer
    Zanotti-Fregonara, Paolo
    Hindie, Elif
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (12) : 2264 - 2266
  • [23] On the effectiveness of recombinant human TSH as a stimulating agent for 131I treatment of metastatic differentiated thyroid cancer
    Paolo Zanotti-Fregonara
    Elif Hindié
    European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 2264 - 2266
  • [24] Clinical use of recombinant human TSH in thyroid cancer patients
    Schlumberger, M
    Ricard, M
    Pacini, F
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2000, 143 (05) : 557 - 563
  • [25] Thyroid cancer radioidine therapy using recombinant human TSH
    Voliotopoulos, V.
    Antypas, C.
    Filou-Giougi, A.
    Pantelis, E.
    Valais, I.
    Stavraka-Kakavaki, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S332 - S332
  • [26] Nuclear Medicine Imaging in Differentiated Thyroid Cancer: Summary of the Korean Thyroid Association Guidelines 2024 from Nuclear Medicine Perspective, Part-I
    Oh, So Won
    Park, Sohyun
    Chong, Ari
    Kim, Keunyoung
    Bang, Ji-In
    Seo, Youngduk
    Hong, Chae Moon
    Lee, Sang-Woo
    NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025, 59 (01) : 1 - 7
  • [27] Nuclear medicine impact on differentiated thyroid cancer diagnosis and treatment
    Medina-Ornelas, Sevastian
    Garcia-Perez, Francisco
    Granados-Garcia, Martin
    GACETA MEDICA DE MEXICO, 2018, 154 (04): : 509 - 519
  • [28] Nuclear medicine therapy of differentiated thyroid cancer: status quo
    Dietlein, M.
    Luster, M.
    Reiners, C.
    ONKOLOGE, 2010, 16 (07): : 678 - +
  • [29] Judicious use of recombinant TSH in the management of differentiated thyroid carcinoma
    Khan, Muhammad Umar
    Nawaz, Mohammad Khalid
    Shah, Mazhar Ali
    Syed, Aamir Ali
    Khan, Amina Iqbal
    ANNALS OF NUCLEAR MEDICINE, 2010, 24 (08) : 609 - 615
  • [30] Judicious use of recombinant TSH in the management of differentiated thyroid carcinoma
    Muhammad Umar Khan
    Mohammad Khalid Nawaz
    Mazhar Ali Shah
    Aamir Ali Syed
    Amina Iqbal Khan
    Annals of Nuclear Medicine, 2010, 24 : 609 - 615
12345